drugset / Trial / NCT02011451

Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis

NCT02011451 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The hypothesis is that 95% pure EGCG can protect brain cells in patients with Multiple Sclerosis. To test this hypothesis we are going to compare the changes in n-Acetyl-Aspartate (a chemical that reflects the number of neurons and their metabolism) over one six between people with MS treated with EGCG at a dose of 400mg twice a day and people with MS treated with a matching sugar pill.

Timeline

Start
2015-12
Primary completion
2017-03
Completion
2017-12

Outcome

Outcome not reported

Stopped (Enrollment): “unable to enroll”

Drugs

EvaluationDrugModalityDoseRoute
Subject Epigallo-catechin-galleate Unknown 200 mg —

Indications